Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway
Jingwei Shao(Fuzhou University), Lee Jia(Henan University)
Cited by 15
Related Papers
<p>Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT</p>
|OncoTargets and Therapy|2019|120
PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: In vitro drug release and in vivo pharmacokinetics assessment
|Journal of Colloid and Interface Science|2016|84
Nitric Oxide Inhibits Hetero-adhesion of Cancer Cells to Endothelial Cells: Restraining Circulating Tumor Cells from Initiating Metastatic Cascade
|Scientific Reports|2014|75
Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib
|Journal of Experimental & Clinical Cancer Research|2019|67